出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/17 05:55:33」(JST)
Names | |
---|---|
Other names
3,4,5,6-Tetrahydro-2,3'-bipyridin
|
|
Identifiers | |
CAS Registry Number
|
3471-05-4 Y |
ChEBI | CHEBI:80787 Y |
ChemSpider | 17923 Y |
InChI
|
|
IUPHAR/BPS
|
347 |
Jmol-3D images | Image |
KEGG | C06522 Y |
PubChem | 18985 |
SMILES
|
|
Properties | |
Chemical formula
|
C10H12N2 |
Molar mass | 160.22 g·mol−1 |
Appearance | Oil |
Odor | Odorless |
Boiling point | 110-120℃ |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Y verify (what is: Y/N?) | |
Infobox references | |
Anabaseine (3,4,5,6-Tetrahydro-2,3’-bipyridine) is an alkaloid toxin produced by Nemertines and Aphaenogaster ants.[1] It is structurally similar to nicotine and anabasine.[2] Similarly, it has been shown to act as an agonist on most nicotinic acetylcholine receptors in the central nervous system and peripheral nervous system.[2]
The iminium form of anabaseine binds to most nicotinic acetylcholine receptors in both the peripheral nervous system and central nervous system. But, there is a higher binding affinity for receptors in the brain with a α7 subunit, as well as skeletal muscle receptors.[3] Binding causes the depolarization of neurons, and induces the release of release of both dopamine and norepinephrine.[2]
Anabaseine causes paralysis in crustaceans and insects, but not in vertebrates, presumably by acting as an agonist on peripheral neuromuscular nicotinic acetylcholine receptors.[2]
The anabaseine molecule consists of a non-aromatic tetrahydropyridine ring connected to the 3rd carbon of a 3-pyridyl ring. It can exist in three forms at physiological pH: a ketone, imine, or iminium structure.[2] Due to conjugation between the imine and 3-pyridyl ring, anabaseine exists as a nearly coplanar molecule.
Spath and Mamoli first synthesized Anabaseine in 1936.[4] The researchers reacted benzoic anhydride with δ-valerolactam to yield N-benzoylpiperidone. Then, N-benzoylpiperidone is reacted with nicotinic acid ethyl ester to produce α-nicotinoyl-N-benzoyl-2-piperidone. This product then is decarboxylated, undergoes a ring closure, and amide hydrolysis to form anabaseine.
Additional synthetic strategies have since been discovered by Bloom,[5] Zoltewicz,[6] Smith,[7] and Villemin[8]
Due to anabaseine’s fairly non-specific binding to nicotinic acetylcholine receptors, the molecule was largely discarded as a useful tool in research or medicine. However, anabaseine derivatives have been identified with a more selective α7 binding profile. One such derivative (GTS-21, 3-(2,4-dimethoxybenzylidene)-anabaseine) has been studied as a drug candidate for cognitive and memory deficits, particularly associated with schizophrenia; it has been studied in phase II clinical trials without progression to phase III.[9]
リンク元 | 「anabasine」「アナバシン」 |
.